Open Access

Erratum to: Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer

Health and Quality of Life Outcomes20108:4

https://doi.org/10.1186/1477-7525-8-4

Received: 30 December 2009

Accepted: 13 January 2010

Published: 13 January 2010

The original article was published in Health and Quality of Life Outcomes 2007 5:70

Correction

We wish to correct a mistake in the abstract and conclusion of our published paper [1]. In the abstract and conclusion, the MID for EQ-VAS score should be reported as 7 rather than 0.07. EQ-VAS scores range from 0 to 100, while EQ-5D index-based scores are anchored by 0 (dead) and 1 (perfect health). The specific wording in the conclusion of the abstract should read "Important differences in EQ-5D utility and VAS scores were similar for all cancers and lung cancer, with the lower end of the range of estimates closer to the MID, i.e. 0.08 for UK-index scores, 0.06 for US-index scores, and 7 for VAS scores.

Notes

Authors’ Affiliations

(1)
Center for Pharmacoeconomic Research, Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago
(2)
Global Health Outcomes, GlaxoSmithKline
(3)
Center for Outcomes Research and Education, Evanston Healthcare and Feinberg School of Medicine, Northwestern University

References

  1. Pickard AS, Neary MP, Cella D: Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual Life Outcomes 2007, 5: 70. 10.1186/1477-7525-5-70PubMed CentralPubMedView ArticleGoogle Scholar

Copyright

© Pickard et al; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement